These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16419393)

  • 1. The identification of mivacurium and metabolites in biological samples.
    Montgomery MA; LeBeau MA; Miller ML; Jufer RA
    J Anal Toxicol; 2005 Oct; 29(7):637-42. PubMed ID: 16419393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic assays with fluorometric detection for mivacurium isomers and their metabolites in human plasma.
    Lacroix M; Tu TM; Donati F; Varin F
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):297-307. PubMed ID: 7735477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of atracurium and its metabolite laudanosine in post-mortem fluids by liquid chromatography/multiple-stage mass spectrometry on an ion trap.
    Ferrara SD; Nalesso A; Castagna F; Montisci M; Vogliardi S; Favretto D
    Rapid Commun Mass Spectrom; 2007; 21(18):2944-50. PubMed ID: 17676709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid method for the quantitation of mivacurium isomers in human and dog plasma by using liquid chromatography with fluorescence detection: application to pharmacokinetic studies.
    Lugo SI; Eddington ND
    J Pharm Biomed Anal; 1996 Apr; 14(6):675-83. PubMed ID: 8807542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective high-performance liquid chromatographic assay with fluorometric detection of the three isomers of mivacurium and their cis- and trans-alcohol and ester metabolites in human plasma.
    Biederbick W; Aydinciouglou G; Diefenbach C; Theisohn M
    J Chromatogr B Biomed Appl; 1996 Oct; 685(2):315-22. PubMed ID: 8953173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of atracurium, cisatracurium and mivacurium with their impurities in pharmaceutical preparations by liquid chromatography with charged aerosol detection.
    Błazewicz A; Fijałek Z; Warowna-Grześkiewicz M; Jadach M
    J Chromatogr A; 2010 Feb; 1217(8):1266-72. PubMed ID: 20036772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic modelling of mivacurium.
    Fisher DM; Hale V
    Br J Anaesth; 1993 Aug; 71(2):328-9. PubMed ID: 8123424
    [No Abstract]   [Full Text] [Related]  

  • 8. The detection and identification of quaternary nitrogen muscle relaxants in biological fluids and tissues by ion-trap LC-ESI-MS.
    Kerskes CH; Lusthof KJ; Zweipfenning PG; Franke JP
    J Anal Toxicol; 2002; 26(1):29-34. PubMed ID: 11890177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs.
    Smith LJ; Schwark WS; Cook DR; Moon PF; Looney AL
    Am J Vet Res; 1999 Sep; 60(9):1051-4. PubMed ID: 10490070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration.
    Lacroix M; Donati F; Varin F
    Anesthesiology; 1997 Feb; 86(2):322-30. PubMed ID: 9054251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi target analysis of putrefactive specimens by liquid chromatography-tandem mass spectrometry to prove multiple poisonings by hypnotics and muscle relaxants.
    Thieme D; Peschel O; Fischer F; Graw M
    Drug Test Anal; 2009 Apr; 1(4):156-61. PubMed ID: 20355193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of mivacurium in plasma by high-performance liquid chromatography.
    Weindlmayr-Goettel M; Weberhofer G; Gilly H; Kress HG
    J Chromatogr B Biomed Appl; 1996 Oct; 685(1):123-7. PubMed ID: 8930760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and quantitation of six non-depolarizing neuromuscular blocking agents by LC-MS in biological fluids.
    Sayer H; Quintela O; Marquet P; Dupuy JL; Gaulier JM; Lachâtre G
    J Anal Toxicol; 2004 Mar; 28(2):105-10. PubMed ID: 15068563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical pharmacology of mivacurium].
    Diefenbach C; Mellinghoff H
    Anaesthesist; 1997 May; 46(5):385-8. PubMed ID: 9245207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of halothane, enflurane and isoflurane on the pharmacodynamics of mivacurium in children].
    Neidhart G; Pabelick C; Kuhn I; Leuwer M; Vettermann J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):293-7. PubMed ID: 8767242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates.
    Kleef UW; Proost JH; Roggeveld J; Wierda JM
    J Chromatogr; 1993 Nov; 621(1):65-76. PubMed ID: 8308088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of action of mivacurium chloride. A comparison of neuromuscular blockade monitoring at the adductor pollicis and the orbicularis oculi.
    Sayson SC; Mongan PD
    Anesthesiology; 1994 Jul; 81(1):35-42. PubMed ID: 8042808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative identification of doxacurium and its breakdown products in postmortem fluids by liquid chromatography-tandem mass spectrometry.
    Montgomery MA; LeBeau MA; Jenkins AJ
    J Anal Toxicol; 2006; 30(1):57-60. PubMed ID: 16620533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Antidepressants in Hair via UHPLC-MS/MS as a Complementary Informative Tool for Clinical and Forensic Toxicological Assessments.
    Ramírez Fernández MD; Wille SM; Hill V; Samyn N
    Ther Drug Monit; 2016 Dec; 38(6):751-760. PubMed ID: 27851687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine.
    Cook DR; Stiller RL; Weakly JN; Chakravorti S; Brandom BW; Welch RM
    Anesth Analg; 1989 Apr; 68(4):452-6. PubMed ID: 2522748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.